Emaretamig
Emaretamig is a humanized IgG1κ monoclonal antibody inhibitor targeting CLDN18 and CD3E. Abdakibart can be used for cancers like gastric and pancreatic cancer research[1].
Product Specifications
CAS Number
3051701-97-1
Product Name Alternative
ASP-2138
UNSPSC
12352100
Target
CD3; Claudin
Related Pathways
Cytoskeleton; Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
References & Citations
[1]Internacionales D C. International Nonproprietary Names for Pharmaceutical Substances (INN) [J]. WHO Drug Information, 2025, 39 (2) .
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Isoform
CLDN18
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
OM626124 100 Tests
Micro Mitochondrial Respiratory Chain ComplexIIActivity Assay Kit
Sign In for Pricing
View Details